Postnatal Corticosteroids Policy for Very Preterm Infants and Bronchopulmonary Dysplasia

Introduction: Postnatal corticosteroids (PNC) are effective for reducing bronchopulmonary dysplasia (BPD) in very preterm neonates but are associated with adverse effects including an increased risk of cerebral palsy. PNC use in Europe is heterogeneous across regions. This study aimed to assess whet...

ver descrição completa

Detalhes bibliográficos
Autor principal: Nuytten, A (author)
Outros Autores: Behal, H (author), Duhamel, A (author), Jarreau, PH (author), Torchin, H (author), Milligan, D (author), Maier, RF (author), Zemlin, M (author), Zeitlin, J (author), Truffert, P (author), EPICE Research Group (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
Bronchopulmonary dysplasia
EPICE cohort
Postnatal corticosteroids
Very preterm infants
Texto completo:https://hdl.handle.net/10216/143316
País:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/143316

Texto Completo

https://hdl.handle.net/10216/143316

Registos relacionados